Text Size

Doctor-Patient Communication in Spanish

This study has been terminated.
Sponsor:
Information provided by:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT00187785
First received: September 14, 2005
Last updated: January 13, 2006
Last verified: August 2005
History of Changes
  Purpose

Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.


Condition Intervention
Upper Respiratory Infection
Hypertension
Diabetes
 Behavioral: Spanish speaker level

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Doctor-Patient Communication in Spanish

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • retention of medical information

Secondary Outcome Measures:
  • patient satisfaction

Estimated Enrollment: 100
Study Start Date: September 2005
Estimated Study Completion Date: December 2006
Detailed Description:

Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire. A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Spanish speaker

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00187785

Locations
United States, California
UMC Family Health Center
Fresno, California, United States, 93702
Sponsors and Collaborators
University of California, San Francisco
Investigators
Principal Investigator: Roger B Mortimer, MD Department of Family Practice
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00187785     History of Changes
Other Study ID Numbers: UMC200552
Study First Received: September 14, 2005
Last Updated: January 13, 2006
Health Authority: United States: Institutional Review Board

Keywords provided by University of California, San Francisco:
Hispanic
communication

Additional relevant MeSH terms:
Hypertension
Respiratory Tract Infections
Common Cold
Vascular Diseases
Cardiovascular Diseases
 Infection
Respiratory Tract Diseases
Picornaviridae Infections
RNA Virus Infections
Virus Diseases

ClinicalTrials.gov processed this record on May 23, 2013